Aldeyra Therapeutics
ALDX
ALDX
111 hedge funds and large institutions have $172M invested in Aldeyra Therapeutics in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 39
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
28% less call options, than puts
Call options by funds: $3.43M | Put options by funds: $4.78M
Holders
111
Holding in Top 10
2
Calls
$3.43M
Puts
$4.78M
Top Buyers
| 1 | +$9.74M | |
| 2 | +$6.43M | |
| 3 | +$5.73M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.22M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.45M |
Top Sellers
| 1 | -$9.8M | |
| 2 | -$5.13M | |
| 3 | -$3.29M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2M |
| 5 |
Two Sigma Investments
New York
|
-$1.49M |